false
Catalog
The Science and Practice of Treating Patients with ...
4 utilizing_buprenorphine_in_the_hospital_setting_ ...
4 utilizing_buprenorphine_in_the_hospital_setting_-_sarah_spencer,_do,_fasam (1080p)
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video focuses on addressing opioid use disorder in hospital settings, emphasizing the identification and treatment of opioid withdrawal, appropriate opioid agonists, acute pain management in opioid-dependent individuals, and planning for transitions of care, especially for patients on buprenorphine. Starting medication for opioid use disorder in hospitals significantly reduces readmission rates and mortality risk. Protocols for initiating buprenorphine treatment, including low-dose overlapping starts, are discussed, along with the role of emergency departments and EMTs in administering buprenorphine. Addressing precipitated withdrawal, using extended-release buprenorphine formulations, and the importance of prompt treatment to improve outcomes are highlighted. Dr. Spencer covered topics on buprenorphine, methadone use, patient challenges accessing medications, patient-directed care, warm handoffs between inpatient and outpatient settings, increased take-home doses of methadone, potential legislation for outpatient methadone prescribing, pain management collaboration among specialists, checking PDMPs for patient histories, and managing pain in patients with opioid use disorder.
Keywords
opioid use disorder
hospital settings
opioid withdrawal
opioid agonists
acute pain management
buprenorphine
transitions of care
medication-assisted treatment
readmission rates
mortality risk
emergency departments
EMTs
precipitated withdrawal
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English